Clinical Trial Update: Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

View source ↗

Summary

A clinical trial evaluating hyperspectral imaging to enhance management of choroidal neovascular membranes in age-related macular degeneration using ranibizumab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Center for Eye Research Australia | Conditions: Macular Degeneration, Choroidal Neovascularization | Status: TERMINATED